View Older Stories View More Recent Stories
-
Qantas picks first female CEO as Alan Joyce prepares to depart
-
The Hershey Company Announces Pricing Of $350,000,000 4.250% Notes Due 2028 And $400,000,000 4.500% Notes Due 2033
-
Healthpeak Properties Inc. (PEAK) Prices Add-On $350M Senior Unsecured Notes Offering
-
Healthpeak Prices Add-On Offering of $350 Million of 5.250% Senior Unsecured Notes due 2032
-
Gilead Sciences to Present at Upcoming Investor Conferences
-
Hershey Foods (HSY) Announces Notes Offering
-
THE HERSHEY COMPANY ANNOUNCES OFFERING OF NOTES
-
Midwest Holding (MDWT) To Be Acquired By Antarctica Capital For $27 Per Share
-
Midwest Holding Inc. To Be Acquired By Antarctica Capital For $27.00 Per Share
-
Teton Merger Corp. Announces Extension of Tender Offers and Consent Solicitations for Senior Notes of TEGNA Inc.
-
Verastem Oncology to Participate in Upcoming Investor Conferences
-
Werewolf Therapeutics to Participate in May Investor Conferences
-
Editas Medicine Announces First Quarter 2023 Results Conference Call and Upcoming Investor Events
-
Editas Medicine Announces First Quarter 2023 Results Conference Call and Upcoming Investor Events
-
IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event
-
International Paper Company (IP) 'valuation looks compelling,' says RBC Capital
-
RBC Capital Upgrades International Paper (IP) to Outperform
-
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MAY HEALTHCARE CONFERENCES
-
SM ENERGY REPORTS FIRST QUARTER 2023 RESULTS
-
Orchid Island Capital Announces First Quarter 2023 Results
-
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Amwell to Participate in Upcoming Investor Conferences
-
Pan American Silver Corp. Announces Consent Solicitations with Respect to Yamana Gold Inc.’s 4.625% Senior Notes Due 2027 and 2.630% Senior Notes Due 2031
-
Valero kicks off US refiners' earnings with Q1 profit beat on robust margins
-
Owens Corning (OC) PT Lowered to $11 at RBC Capital
-
RBC Capital on Biogen (BIIB): 'CMS Makes It Clear - Leqembi Will Be Broadly Reimbursed - Should Reduce Overhang'
-
MindMed to Participate in May Investor Conferences
-
Associated Banc-Corp to Attend Three Second Quarter Investor Events
-
Penumbra, Inc. to Present at Upcoming Investor Conferences
-
Lower output, high costs to pressure Newmont, Barrick earnings
-
SouthState names Consumer and Small Business Banking, Government Guaranteed Lending and Premier Private Client Group Leaders
-
Outset Medical to Present at Upcoming Investor Conferences
-
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023
-
RBC Capital Reiterates Outperform Rating on Alphabet (GOOGL) into earnings
-
Axonics to Participate in Upcoming Investor Conferences
-
IDEAYA Biosciences (IDYA) Prices 7.44M Share Offering at $18.50/sh
-
IDEAYA Announces Pricing of Public Offering
-
Summit Midstream Partners, LP Schedules First Quarter 2023 Earnings Call
-
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
-
Houlihan Lokey (HLI) Strengthens Capital Placement Capabilities With New Senior Hire
-
Houlihan Lokey Strengthens Capital Placement Capabilities With New Senior Hire
-
Nevro Announces Participation in Upcoming Investor Conferences
-
Chord Energy Schedules First Quarter 2023 Conference Call for May 4, 2023
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
HCA Healthcare, Inc. to Present at May Healthcare Conferences
-
RBC Capital Reiterates Outperform Rating on Shift4 Payments (FOUR), 'we believe management’s comments should bring some ease to investors'
-
Tesla (TSLA) PT Lowered to $212 at RBC Capital
-
Morgan Stanley, Deutsche and others raise UK rate-hike forecasts
-
Rivian (RIVN) downgraded to Sector Perform at RBC Capital on limited near-term catalysts


